Role of Stat3 in suppressing anti-tumor immunity

This publication has 50 references indexed in Scilit:

• IL-21 Is Produced by Th17 Cells and Drives IL-17 Production in a STAT3-dependent Manner
  Journal of Biological Chemistry, 2007
• Dendritic cells with TGF-β1 differentiate naïve CD4⁺CD25⁻T cells into islet-protective Foxp3⁺regulatory T cells
  Proceedings of the National Academy of Sciences, 2007
• Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment
  Nature Reviews Immunology, 2007
• Nucleophosmin/anaplastic lymphoma kinase (NPM/ALK) oncoprotein induces the T regulatory cell phenotype by activating STAT3
  Proceedings of the National Academy of Sciences, 2006
• The BRAF–MAPK signaling pathway is essential for cancer-immune evasion in human melanoma cells
  The Journal of Experimental Medicine, 2006
• Selective regulatory function of Socs3 in the formation of IL-17-secreting T cells
  Proceedings of the National Academy of Sciences, 2006
• Loss of SOCS3 in T helper cells resulted in reduced immune responses and hyperproduction of interleukin 10 and transforming growth factor–β1
  The Journal of Experimental Medicine, 2006
• Regulatory T cells, tumour immunity and immunotherapy
  Nature Reviews Immunology, 2006
• The STATs of cancer — new molecular targets come of age
  Nature Reviews Cancer, 2004
• Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells
  Nature Medicine, 1996